Results 241 to 250 of about 477,848 (284)
Objective The multinational, phase 3, double‐blind, placebo‐controlled TULIP‐SC trial evaluated the efficacy and safety of subcutaneous anifrolumab in adults who have moderate to severe systemic lupus erythematosus (SLE) activity, despite receiving standard therapy. Methods Adults with SLE received subcutaneous anifrolumab 120 mg or placebo once weekly
Susan Manzi +12 more
wiley +1 more source
The Role of Probiotics and Their Postbiotic Metabolites in Post-COVID-19 Syndrome. [PDF]
Jach ME +7 more
europepmc +1 more source
Objective Ear, nose, and throat (ENT) manifestations are common in antineutrophil cytoplasmic antibody (ANCA)–associated vasculitis (AAV). There is an unmet need for drugs to target these manifestations. Granuloma formation is characteristic of proteinase 3 (PR3)–AAV. In a zebrafish model, niclosamide inhibits PR3‐induced granuloma formation.
Benjamin Lim +4 more
wiley +1 more source
Editorial: Exploring neurotological health concerns post-COVID-19 infection. [PDF]
Quimby AE.
europepmc +1 more source
Abstract The recent coronavirus disease (COVID‐19) forced pre‐university professionals to modify the educational system. This work aimed to determine the effects of pandemic situation on students' access to medical studies by comparing the performance of medical students.
José Manuel García +9 more
wiley +1 more source
Waning immunity and the future of booster vaccination strategies in global vaccine programs post COVID-19. [PDF]
Biswas R +6 more
europepmc +1 more source
Body donor programs in Australia and New Zealand: Current status and future opportunities
Abstract Body donation is critical to anatomy study in Australia and New Zealand. Annually, more than 10,000 students, anatomists, researchers, and clinicians access tissue donated by local consented donors through university‐based body donation programs. However, little research has been published about their operations.
Rebekah A. Jenkin, Kevin A. Keay
wiley +1 more source
Rediscovering parainfectious encephalopathy in the post-COVID-19 era. [PDF]
Bai L, Geng C, Guan H.
europepmc +1 more source

